Survival and normal neurological outcome after CPR with periodic Gz acceleration and vasopressin

Resuscitation. 2003 Feb;56(2):215-21. doi: 10.1016/s0300-9572(02)00319-2.

Abstract

Background: We showed previously that whole body periodic acceleration along the spinal axis (pGz) is a novel method of cardiopulmonary resuscitation (CPR). The ultimate assessment of the value of any CPR technique is the neurological outcome after using such a technique. In this study, we determined the neurological outcome in pigs after prolonged pGz-CPR, with administration of vasopressin immediately prior to defibrillation. Neurological outcome after pGz-CPR was compared to a control group where no intervention occurred for the same time period (C-NoInterv).

Methods and results: Ventricular Fibrillation (VFIB) was induced in 12 animals. After a 3 min non-interventional interval, the animals received either pGz-CPR (n=7), or C-NoInterv (n=5) for 15 min. After 18 min of VFIB, a single dose of vasopressin (0.8 U/kg) was administered along with sodium bicarbonate and bretylium, and defibrillation was attempted. All animals in the pGz-CPR group had return of spontaneous circulation (ROSC) and normal neurological assessment at 24 h. Neurologic outcome remained normal at 48 h. In contrast, none of the animals in the C-NoInterv had ROSC.

Conclusion: Prolonged pGz-CPR, with administration of vasopressin immediately prior to defibrillation results in normal neurological outcomes at 24 h.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acceleration
  • Animals
  • Cardiac Output / physiology
  • Cardiopulmonary Resuscitation / adverse effects*
  • Cardiopulmonary Resuscitation / methods*
  • Cardiopulmonary Resuscitation / mortality
  • Cerebrovascular Circulation / physiology
  • Electric Countershock
  • Female
  • Male
  • Neurologic Examination
  • Probability
  • Random Allocation
  • Reference Values
  • Refractory Period, Electrophysiological
  • Statistics, Nonparametric
  • Survival Rate
  • Swine
  • Treatment Outcome
  • Vasopressins / pharmacology*
  • Ventricular Fibrillation / mortality
  • Ventricular Fibrillation / therapy*

Substances

  • Vasopressins